Researchers develop a 'time bomb' to fight cardiovascular disease
- Details
- Category: Research
In Switzerland, more than 20,000 people (37% of all deaths) die of cardiovascular disease caused by atherosclerosis each year. Treatment options are currently available to people who suffer from the disease but no drug can target solely the diseased areas, often leading to generalized side effects.
Alzheimer's vaccine trial a success
- Details
- Category: Research
A study led by Karolinska Institutet reports for the first time the positive effects of an active vaccine against Alzheimer's disease. The new vaccine, CAD106, can prove a breakthrough in the search for a cure for this seriously debilitating dementia disease. The study is published in the distinguished scientific journal Lancet Neurology.
New immune therapy shows promise in kidney cancer
- Details
- Category: Research
An antibody that helps a person's own immune system battle cancer cells shows increasing promise in reducing tumors in patients with advanced kidney cancer, according to researchers at Beth Israel Deaconess Medical Center.
Carfilzomib demonstrates efficacy as new frontline treatment regimen for multiple myeloma
- Details
- Category: Research
Results from a study published online in Blood, the Journal of the American Society of Hematology (ASH), demonstrate that inclusion of carfilzomib, a novel targeted therapy for multiple myeloma, in combination with lenalidomide and low-dose dexamethasone, resulted in complete or near complete remission in a majority of patients with newly diagnosed multiple myeloma.
New research yields insights into Parkinson's disease
- Details
- Category: Research
Researchers at the University of Toronto Scarborough (UTSC) used an innovative technique to examine chemical interactions that are implicated in Parkinson's Disease. The work details how a protein called alpha-synuclein interacting with the brain chemical dopamine can lead to protein misfolding and neuronal death.
Thioridazine, successfully kills cancer stem cells in the human
- Details
- Category: Research
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.
Calcium supplements linked to significantly increased heart attack risk
- Details
- Category: Research
Calcium supplements might increase the risk of having a heart attack, and should be "taken with caution," concludes research published in the online issue of the journal Heart. Furthermore, boosting overall calcium intake from dietary sources confers no significant advantage in terms of staving off heart disease and stroke, the findings indicate.
More Pharma News ...
- Biomarker predicts response to cancer treatment
- In drug-approval race, US FDA ahead of Canada, Europe
- Blood pressure drugs don't protect against colorectal cancer
- Vitamin K2: New hope for Parkinson's patients?
- H1N1 discovery paves way for universal flu vaccine
- Some HDL, or 'good' cholesterol, may not protect against heart disease
- Potential to revive abandoned cancer drug by nanoparticle drug delivery